Table 3.
Parameters | HL60 | U937 | Control |
---|---|---|---|
sVCAM-1 (pg/mL) | 854.77 (448.04–931.71) | 1286.26 (1136.05–1511.09)## | – |
MMP-2 (pg/mL) | 200.24 (186.57–369.48) | 98.38 (6.25–193.30)# | – |
MMP-9 (pg/mL) | 5894.30 (5124.31–8637.63) | 1263.17 (628.28–2876.39)## | – |
CXCL12 (pg/mL) | 426.71 (182.01–721.56) | 986.23 (378.33–1216.69) | 143.32 |
CCL2 (pg/mL) | 324.21 (167.14–1024.71) | 90.52 (9.59–172.61)# | 4.05 |
VEGF-A (pg/mL) | 7078.21 (5373.40–17,453.72) | 3334.28 (1076.67–4560.29)## | – |
Notes: The concentrations of C&Ckines were measured in the supernatant of HL60/U937 and HBMVECs cocultured system.
P<0.05 and
P<0.01 when compared with HL60 group. “–”: not detected.
Abbreviations: C&Ckines, cytokines and chemokines; HBMVECs, human brain microvascular endothelial cells.